Bikash has over 30 years of experience in design and development of pharmaceutical, biotechnology, medical device and IVD products. He has successfully commercialized over a dozen products in his career. Bikash has held senior management positions in several firmsprior to joining Pharmatech. He is a certified Lead Assessor and Lean Six Sigma Master Black Belt and a frequent speaker at industry conferences.He is a member of the USP National Advisory Committee for API's and Excipients, LSIT Technical Advisory Board and The Stem Cell Partnering Advisory Board. Bikash currently provides recurring editorials to both Pharmaceutical Manufacturing and Controlled Environments magazine as an industry thought leader and is a member of their editorial advisory board. He is a member of cPHl's Expert Industry Panel and a member of the RFID Alliance with expertise in the effect ive applica tion of se cu rity and RFID in the pharmace utica l su pply ch ain. He has designed and built biotech facilities globally and has established global supply chain frameworks for both large and small organizations. He holds a BS in Biochemistry from University of California San Diego and a BS in Chemical Engineering from University of California San Diego.

Duncan Emerton, PhD currently holds the position of Director, Custom Intelligence & Analytics at Informa Pharma Intelligence. A global expert in biosimilars and the pharmaceutical/biotech space, Dr.Emerton is also a well-known speaker and thought-leader with an established reputation within the healthcare markets Informa Pharma Intelligence serves. Dr. Emerton has more than 20 years of experience in the pharmaceutical industry, spanning roles in non-clinical and clinical R&D, sales, marketing, medical affairs, strategic consulting and business analysis. Most recently, Duncan was at FirstWord Group, where he was responsible for all syndicated disease analysis across a wide range of therapy areas, including respiratory, autoimmune, neurology, rare diseases and oncology.

Over 25 years pharmaceutical experience in Boehringer Ingelheim, including roles in Quality, local sourcing (chemical and Pharmaceutical plants), Global sourcing (Chemical, APIs, CMOs, packaging components),
Corporate EHS&S (Senior EHS&S manager, 3rd party auditing program) and Global 3PM Chemicals Manager. ​

Currently I am in a group to manage the supply of outsourced/ purchased APIs (as well as strategic Starting Materials and Intermediates for our Chemical Manufacturing) for BI’s Pharmaceutical manufacturing Network. I am also Corporate EHS&S auditor to our sites and to our third party.

I am the PSCI (Pharmaceutical supply chain initiative) BI representative since 2013. Currently co-chair of the Communications committee and also part of other committees like AMR/PIE, Audit, …​

I have a PhD in Chemistry from the University Autonoma of Barcelona (UAB) and an MBA from Universidad Pompeu Fabra of Barcelona. ​

I live in Sant Cugat del Vallés, a village nearby Barcelona (Spain). I’m married with 4 kids and my interests include soccer (supporter of FC Barcelona), gardening and riding my mountain bike (at least twice a week).​ ​

Fiona Barry, MA, is the Associate Editor of PharmSource, responsible for PharmSource’s editorial content and publication of PharmSource’s Trend Reports, monthly Bio/Pharmaceutical Outsourcing Reports, and quarterly Emerging Market Outsourcing Reports. Fiona previously worked as an investigative journalist for GlobalData’s drug development news service, formerly BioPharm Insight, reporting scoops on clinical trials, contract pharma, rare diseases, and women’s health. She is also an experienced financial journalist and a frequent expert speaker at pharmaceutical industry conferences. Fiona worked for several years as a reporter at William Reed Business Media’s French office, breaking global manufacturing, regulatory, and outsourcing news for the biopharmaceutical industry for in-PharmaTechnologist, Outsourcing-Pharma, and BioPharmaReporter. She holds an MA in English and a BA in English and Philosophy from the University of Bristol, UK and works in GlobalData’s London office.

Dr. Chauhan is an Associate Professor in Pharmaceutical Sciences at Creighton University, NE, USA; with a research lab working in the area of developing novel drug delivery systems for poorly soluble compounds. He completed his PhD from MCPHS University, Boston, MA. He had published more than 25 peer reviewed article, five book chapters and presented around 50 posters in national and international conferences. He serves as reviewer and editorial board in many reputed pharmacy journals. He is a member of American Association of Pharmaceutical Scientist (AAPS) and American Chemical Society (ACS).

Wayne Weiner is the principal and founder of Pharmatech Solutions LLC (PTS), a specialty consultancy providing strategic planning, M&A advisory, and business
development services for the pharmaceutical, nutrition, and personal care industries. Wayne has been engaged in over 30 transactions, with total closed deal value of ~$5 Bn.

Prior to founding PTS in 2017, Wayne held Vice President Strategy and Corporate Development roles for DSM pharmaceutical Products (“DPP”, a business unit of Royal DSM N.V.) and Patheon (acquired in 2017 by Thermo Fisher Scientific), one the industry’s leading pharmaceutical custom manufacturing organizations. In these assignments
he played a key role in multiple transactions, including the $700M merger of DPP with Patheon in 2014.

Wayne also held Vice President Sales and Marketing positions for DPP’S North American pharmaceutical contract manufacturing business, and for Synthon Chiragenics Corporation, a leading supplier of specialized pharmaceutical intermediates. In each assignment, he drove new business growth through the implementation of
strategic, customer focused sales initiatives.

Wayne was an American Cancer Society post-doctoral fellow at Columbia University in New York. He earned his Ph.D. in chemistry from the University of California
Berkeley, and B.Sc. degree in chemistry from the University of California, Los Angeles, which included studies at Georg-August University, Goettingen, Germany.

Emil W. Ciurczak has advanced degrees in Chemistry from Rutgers and Seton Hall Universities and has been in the pharmaceutical industry since 1970. In 1983, he introduced NIR spectroscopy to pharmaceuticals and consulted for instrument companies. He has published over four dozen articles in refereed journals, over 250 magazine columns, and presented over two hundred technical papers. Since 2005, Emil has been Contributing Editor for Pharmaceutical Manufacturing magazine (for Spectroscopy; 1987-2007 and PharmaEvolution.com 2013-4). He has written and edited several texts and chapters including “Handbook of NIR Analysis” (3 editions), “Pharma and Med Applications of NIR (2 editions),” “Molecular Spectroscopy Workbench,” and chapters on NIR applications in life sciences. Emil sits on several magazine editorial boards, is active in SAS, CNIRS, and was 2002 chair for IDRC and was the 2004 recipient of the EAS Achievements in NIR Award. He has been teaching at a college level since 1979; presenting short courses (NIR, Raman, Design of Experiments, and PAT/QbD) in the US, Europe, South America, and Asia. He holds patents for NIR-based devices and software and consults with various pharmaceutical companies, instrument manufacturers, and the FDA. He was on the PAT Sub-Committee (Validation) for the FDA in 2002 and was a member of the PAT Expert Committee for the USP..

Dan Stanton is editor and founder of BioProcess Insider, an online publication focused on reporting the latest business news and opinion across the biomanufacturing space, and part of the BioProcess International brand. Formerly editor of Biopharma-Reporter and in-Pharmatechnologist, Dan has particular expertise in biotech, bioprocessing methods and equipment, drug delivery, regulatory affairs and business development. Dan is a native Londoner now based in Montpellier, France.

Adrian van den Hoven was appointed Director-General of the Medicines for Europe (formerly European Generic and Biosimilar Medicines Association - EGA) on 1 September 2013. Before this, he was Deputy Director-General of BUSINESSEUROPE, responsible for the International Relations and Industry departments. He worked as an International Relations researcher and adjunct professor in Italy (EUI), France (Nice), and Canada (Windsor) prior to joining BUSINESSEUROPE in 2003. He received his doctorate in Political Science from the University of Nice, France, in 2000.

Mayur is an accomplished leader with over 18 years of innovative pharma digital health and medical device development experience. He advises pharmaceutical companies on digital health innovation, technology strategy, product development, regulatory, and commercialization aspects. Mayur has led a wide range of development programs in PA and his past employments. He has a strong track record in leading the development of innovative devices and techniques. Mayur has helped PA’s clients to address some of the most stringent technical needs and challenges.

Dr Pascale Gauthier is Pharmacist with research works (master of Biopharmacy) on ‘New gelification method for vegetal oils’, specific master (DEA) in Pharmacokinetics ‘Pharmacokinetic study of antihypertensive drug and its metabolites after single and repeated dose’ and a PhD in Pharmaceutical Technology on ‘Rotogranulation process used for manufacture of spheres’.
She was involded in several patents, international publications (Int Journ of Cosm Sc, STP Pharma Pratiques, Pharm Dev Techn, Therapeutic Delivery, Journ of Pers Med., Doses) and invited speaker in different international events (Glatt TTC, Visiongain, PackVision, ADF, Pharmapack, Informa sessions on ‘drug development’, Formulations Strategies and Drug Delivery Summit). She is a member creation of PharmaDesign, and invited in the scientific committee of panel experts for ‘I love pack since 1947’ Exhibition of WorldPack in Paris. Since 1996 she is associated Pharmacist in a Pharmacy and in charge of Marketing and Design courses in the Faculty of Pharmacy of Clermont-Ferrand.

Michael holds a MSc degree in Chemistry and an MEng degree in chemical engineering. Since 1984 he has been active in publishing, semiconductor research, and development, of medical devices, most recently as managing director of the NVC Netherlands Packaging Centre and of HCPC Europe. NVC is the association of over 500 companies addressing the activity of packaging throughout the supply chain of packaged products. The NVC membership, innovation projects (Packaging Innovation Contest De Gouden Noot, Design for Intended Use DIU, Web Retail Packaging, PUMA to end packaging as an environmental issue worldwide, Pharmaceutical Packaging Innovation, Innovation in Packaging Print, etc.), information services and education program (physical classroom-based and Live Online Learning with worldwide access and live tutors), stimulate the continuous improvement of packaging. HCPC Europe unites businesses to stimulate pharmaceutical packaging innovation for better healthcare, improving patients’ lives especially by enhancing compliance and adherence to medication regimes. .

Michael McCoy is executive editor for business at Chemical & Engineering News, responsible for the magazine's coverage of the business of chemistry. He received his B.A. in chemistry and English from Cornell University in 1985. .

TBC

TBC

TBC

TBC

TBC

TBC

TBC

TBC